Results 171 to 180 of about 12,608 (191)
Some of the next articles are maybe not open access.

TaqMan Multiplex qPCR Method to Genotype PARG Knockout Mice

2022
Members of PARP family are responsible for poly(ADP-ribose) (pADPr) posttranslational modification synthesis. They are intensively studied proteins with more than 20,500 related papers in PubMed database search to date. PARG, the main enzyme that degrades pADPr, is unfairly attracted less attention, and 40 times less papers (a little more than 500) are
Yaroslava, Karpova, Alexei V, Tulin
openaire   +2 more sources

PARG inhibition induces nuclear aggregation of PARylated PARP1

2023
AbstractPARG inhibitors are currently under clinical development for the treatment of DNA repair-deficient cancers, however, their precise mechanism of action is still unclear. Here we report that PARG inhibition causes increased nuclear PARylated PARP1 that limits PARP1 chromatin binding in response to DNA damage.
Sateja Paradkar   +6 more
openaire   +1 more source

PARP and PARG as novel therapeutic targets

Drugs of the Future, 2002
Poly(ADP-ribose) is synthesized by poly(ADP-ribose) polymerase (PARP) from β-nicotinamide adenine dinucleotide (NAD + ). It is mainly degraded by poly(ADP-ribose) glycohydrolase (PARG). The expanding family of PARP currently consists of PARP 1 - 3 , vPARP, Tankyrase 1 - 2 , 2 , and more members are being characterized.
null Zhang, J., null Li, J.-H.
openaire   +1 more source

PARG inhibition induces nuclear aggregation of PARylated PARP1

Structure
Poly (ADP-ribose) glycohydrolase (PARG) inhibitors are currently under clinical development for the treatment of DNA repair-deficient cancers; however, their precise mechanism of action is still unclear. Here, we report that PARG inhibition leads to excessive PARylated poly (ADP-ribose) polymerase 1 (PARP1) reducing the ability of PARP1 to properly ...
Sateja Paradkar   +8 more
openaire   +2 more sources

Bacterial PARP/PARG enzymes – filogenetic and structural comparisson

2021
ADP-ribosylation is an evolutionarily conserved reversible post-translational modification utilized from bacteria to humans. Bacteria were historically considered to be devoid of PAR metabolism, despite the fact many harbour genes homologous to the eukaryotic PARPs and PARGs.
Mikolčević, Petra   +2 more
openaire   +1 more source

PARG INHIBITORY COMPOUNDS

2016
The present invention relates to compounds of formula I that function as inhibitors of PARG (Poly ADP-ribose glycohydrolase) enzyme activity: wherein R1a, R1b, R1c, R1d, R1e, W, X1, X2, X3, X4, X5, X6, X7, c are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions
Jordan, Allan   +7 more
openaire   +1 more source

PARGE: parametric geocoding based on GCP-calibrated auxiliary data

SPIE Proceedings, 1998
Nearly all current imaging spectroscopy data are obtained by scanning airborne systems. The stability of such systems is always worse than that of spaceborne platforms. Thus, geometric distortions occur due to variations of the flightpath as well as of the attitude of the plane. These distortions cannot be corrected simply by ground control point based
Daniel Schlaepfer   +2 more
openaire   +1 more source

Targeting PARG in HCC

Nature Reviews Gastroenterology & Hepatology, 2022
openaire   +2 more sources

Home - About - Disclaimer - Privacy